RINIALER

This brand name is authorized in Spain, Malta

Active ingredients

The drug RINIALER contains one active pharmaceutical ingredient (API):

1 Rupatadine UNII XJ6OT32M93 - RUPATADINE FUMARATE

Rupatadine is a second-generation antihistamine, long-acting histamine antagonist, with selective peripheral H1-receptor antagonist activity. Some of the metabolites (desloratadine and its hydroxylated metabolites) retain an antihistaminic activity and may partially contribute to the overall efficacy of the drug. Read about Rupatadine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RINIALER Tablet	Medicines Authority (MT)	MPI, EU: SmPC
RINIALER Oral solution	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AX28	Rupatadine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AX Other antihistamines for systemic use
Discover more medicines within R06AX28

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 65367, 75990, BE272045IP
Country: MT	Medicines Authority	Identifier(s): MA004/00601, MA004/00801, PI908/21001A